Prostatitis

Treatment is updated daily with the most recent articles listed on top.
To view only the last month's articles for the other sub-topics, go to our Monthly Online Newsletters page

If you have any questions regarding our Search Reports, please contact us at info@infomedsearch.com.

Prostatitis

General Information

NEWS:

ARTICLES:

JOURNAL ARTICLES:

A proposal of subcategorization of bacterial prostatitis: NIH category I and II diseases can be further subcategorized on analysis by therapeutic and immunological procedures. (Int J Urol. 2006) "CONCLUSIONS: Bacterial prostatitis could be classified into primary and recurrent chronic infections in each of the febrile (category I) and afebrile (category II) illnesses. A cefem regimen in varying doses was a clue for differential diagnosis as it did not affect the pathogens in the prostatic ducts or acini unless heavy urine reflux occurred in the ductal draining systems. Macrophages and immunoglobulins, especially IgM, in the EPS were useful immunological parameters to differentiate primary and recurrent infections of the prostate. Fluoroquinolones or sulfamethoxazole-trimethoprim should not be employed in acute urinary infections in male patients until the confirmation of prostatic infection to avoid injudicious use of them, which might cause an increasing prevalence of resistant uropathogens in the community. The evacuation of the prostate by repetitive massage seemed to be effective to enhance the prompt eradication of pathogens from the prostatic tissue and to keep patients asymptomatic throughout the course of the disease by preventing tissue pressure elevation."

A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the national institutes of health chronic prostatitis cohort study. (J Urol. 2006)

Catastrophizing and Pain-Contingent Rest Predict Patient Adjustment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome. (J Pain. 2006)

Comorbid LUTS and erectile dysfunction: optimizing their management. (Curr Med Res Opin. 2006)

Correlation between ultrasound alterations of the preprostatic sphincter and symptoms in patients with chronic prostatitis-chronic pelvic pain syndrome. (J Urol. 2006) "CONCLUSIONS: Ultrasound evaluation of the bladder neck-posterior urethra in patients with chronic prostatitis-chronic pelvic pain syndrome led us to identify a set of lesions that cannot be found in healthy subjects. The measurement of hypoechoic periurethral zone volume, posterior prostate lip thickness and bladder neck thickness could be useful for following patients with chronic prostatitis-chronic pelvic pain syndrome and maybe for better understanding the complicated pathophysiological mechanisms of chronic nonbacterial prostatitis."

Coryneform bacteria in semen of chronic prostatitis patients. (Int J Androl. 2006) "We suggest that although coryneforms are generally considered as saprophytes, they are not uniform and some species (Corynebacterium group G and Arthrobacter sp.) may be associated with inflammatory prostatitis."

Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer. (Int Urol Nephrol. 2006) Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer. (Int Urol Nephrol. 2006)

[Epidemiological study of chronic prostatitis patients with depression symptoms] (Zhonghua Nan Ke Xue. 2006) "CONCLUSION: CP patients mostly have depression problems, which are closely correlated with CP and contribute to the recurrence, refractoriness and discontented outcome of the disease."

Inflammation and prostate cancer. (Can J Urol. 200 6)

[Outline of the effects of chronic prostatitis on male fertility] (Zhonghua Nan Ke Xue. 2006)

Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. (J Urol. 2006)

[Prostatitis--a frequently unrecognized disease] (Ther Umsch. 2006)

Relationship between Serum Prostate Specific Antigen and the Pattern of Inflammation in Both Benign and Malignant Prostatic Disease in Middle Eastern Men. (Int Urol Nephrol. 2006)

Seminal Microflora in Asymptomatic Inflammatory (NIH IV Category) Prostatitis. (Eur Urol. 2006) "CONCLUSIONS: Unlike the controls the NIH IV category prostatitis patients harbour abundant polymicrobial microbiocenosis in their semen, containing anaerobic, microaerophilic and aerobic bacteria. Detection of IL-6 in seminal plasma serves as an additional tool for diagnosing NIH IV category prostatitis."

Sexual dysfunction in the patient with prostatitis. (Curr Urol Rep. 2006) "Prostatitis (chronic prostatitis/chronic pelvic pain syndrome ) is a common condition in men that accounts for a significant number of visits to a medical doctor or urologist. It is one of the most widely diagnosed conditions in men who attend urologic clinics. Erectile dysfunction, defined as the consistent inability to obtain and/or maintain a penile erection sufficient for adequate sexual relations, also is a common problem. This review explores the links between sexual dysfunction and prostatitis. Most of the data linking lower urinary tract symptoms and erectile dysfunction suggest that lower urinary tract symptoms impair the overall quality of life and that a low quality of life contributes to or causes erectile dysfunction."

The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis. (Int Urol Nephrol. 2006) "CONCLUSION: High serum PSA levels may correlate with asymptomatic inflammatory prostatitis with high aggressiveness score in BPH patients without clinical prostatitis."

The effect of Chlamydia trachomatis infection of the prostate gland on the concentration of citric acid. (Arch Immunol Ther Exp (Warsz). 2006)

Urodynamic studies in the evaluation of young men presenting with lower urinary tract symptoms. (Int J Urol. 2006) "The main pre-UDS diagnoses included prostatitis in seven (14%), overactive bladder in seventeen (34%) and benign prostatic hyperplasia in nine (18%). Pre-UDS management ranged from anticholingeric agents for thirteen (26%), alpha-adrenergic antagonists for nine (18%), antibiotics for six (12%). Abnormal UDS were noted in 36 (72%), including detrusor overactivity in 9 (18%), detrusor underactivity/acontractility in 5 (10%) and bladder outlet obstruction in 21 (42%). Fourteen (28%) had primary bladder neck dysfunction and five (10%) had benign prostatic hyperplasia. Post-UDS management included anticholingeric agents for ten (26%), alpha-adrenergic antagonists for seventeen (34%), catheterization for four (10%), behavioral therapy for three (6%), surgery for three (6%). None were prescribed antibiotics. Following UDS, the diagnosis had to be updated in 40 (80%) and concomitant change in management was required in 34 (68%)."

Xanthogranulomatous prostatitis: A mimick of carcinoma prostate. (World J Surg Oncol. 2006)

Go to the top